Cornerstone Wealth Management’s AstraZeneca AZN Stock Holding History

Cornerstone Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$518K	Buy	2,730 +714	+35%	+$134K	0.02%	484
2026 Q1	$398K	Buy	2,016 +851	+73%	+$164K	0.02%	507
2025 Q4	$214K	Buy	+1,165	New	+$204K	0.01%	643
2018 Q4	–	Sell	-32,273	Closed	-$1.87M	–	392
2018 Q3	$1.87M	Buy	32,273 +3,720	+13%	+$281K	0.02%	522
2018 Q2	$1.64M	Buy	+28,553	New	+$2.05M	0.02%	598

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Cornerstone Wealth Management's AZN Position: Q2 2026 in Review

Cornerstone Wealth Management increased its AstraZeneca (AZN) stake by 35% in Q2 2026, buying an estimated $134K and bringing the position to 2,730 shares worth $518K. The position accounts for 0.02% of the portfolio, ranked #484.

Cornerstone Wealth Management first reported a position in AZN in Q2 2018 and has held it in 5 quarters since. The position peaked at $1.87M in Q3 2018. 444 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cornerstone Wealth Management held 2,730 shares of AstraZeneca worth $518K as of Q2 2026.
Cornerstone Wealth Management bought 714 AstraZeneca shares in Q2 2026, an estimated $134K.
AstraZeneca made up 0.02% of Cornerstone Wealth Management's portfolio in Q2 2026, its #484 holding.
Cornerstone Wealth Management first reported a position in AstraZeneca in Q2 2018 and has held it in 5 quarters since.
Cornerstone Wealth Management's AstraZeneca position peaked at $1.87M in Q3 2018.
444 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.